Anavex Life Sciences Corp. (AVXL)
2.695
-0.02
(-0.55%)
USD |
NASDAQ |
May 22, 16:00
2.695
0.00 (0.00%)
Pre-Market: 20:00
Anavex Life Sciences EPS Diluted (Quarterly) : -0.0638 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.681M |
| Total Expenses (Quarterly) | 5.681M |
| Enterprise Value | 118.00M |
| Earnings Yield | -17.25% |
| Normalized Earnings Yield | -17.25 |